Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-positive Metastatic Breast Cancer × atezolizumab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 12 Lung Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Small Cell Lung Carcinoma 6 Neoplasms 6 Urinary Bladder Neoplasms 4 Carcinoma, Renal Cell 4 Squamous Cell Carcinoma of Head and Neck 3 Neoplasm Metastasis 3 Liver Neoplasms 3 Colorectal Neoplasms 3 Solid Tumors 2 Sarcoma, Alveolar Soft Part 2 Ovarian Neoplasms 2 Osteosarcoma 2 Nasopharyngeal Carcinoma 2 Melanoma 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Small Cell Lung Cancer Extensive Stage 1 Sarcopenia 1 Sarcoma, Clear Cell 1 Sarcoma 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Papillary renal cell carcinoma, sporadic 1 Pancreatic Neoplasms 1

Interventions

tucatinib 1 Fulvestrant 1 Alpelisib 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡